Literature DB >> 31970206

Is Pallido-Pyramidal Syndrome Still a Useful Concept? Yes.

Christine Tranchant1,2,3.   

Abstract

Entities:  

Year:  2019        PMID： 31970206      PMCID： PMC6962687          DOI： 10.1002/mdc3.12845

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  18 in total

Review 1.  The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.

Authors:  Jin-Sung Park; Nicholas F Blair; Carolyn M Sue
Journal:  Mov Disord       Date:  2015-04-21       Impact factor: 10.338

Review 2.  Isolated and combined dystonia syndromes - an update on new genes and their phenotypes.

Authors:  B Balint; K P Bhatia
Journal:  Eur J Neurol       Date:  2015-01-29       Impact factor: 6.089

3.  Severe early-onset impulsive compulsive behavior and psychosis in PLA2G6-related juvenile Parkinson's disease.

Authors:  T Wirth; S Weibel; S Montaut; K Bigaut; G Rudolf; J Chelly; C Tranchant; M Anheim
Journal:  Parkinsonism Relat Disord       Date:  2017-05-19       Impact factor: 4.891

Review 4.  Pallidopyramidal disease: a misnomer?

Authors:  Martin W I M Horstink; Marieke C Dekker; Pasquale Montagna; Vincenzo Bonifati; Bart P van De Warrenburg
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

5.  New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.

Authors:  Penelope Hogarth; Allison Gregory; Michael C Kruer; Lynn Sanford; Wendy Wagoner; Marvin R Natowicz; Robert T Egel; S H Subramony; Jennifer G Goldman; Elizabeth Berry-Kravis; Nicola C Foulds; Simon R Hammans; Isabelle Desguerre; Diana Rodriguez; Callum Wilson; Andrea Diedrich; Sarah Green; Huong Tran; Lindsay Reese; Randall L Woltjer; Susan J Hayflick
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

6.  Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation.

Authors:  Patrick F Chinnery; Douglas E Crompton; Daniel Birchall; Margaret J Jackson; Alan Coulthard; Anne Lombès; Niall Quinn; Adrian Wills; Nicholas Fletcher; John P Mottershead; Paul Cooper; Mark Kellett; David Bates; John Burn
Journal:  Brain       Date:  2006-12-02       Impact factor: 13.501

7.  Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).

Authors:  Alejandro Estrada-Cuzcano; Shaun Martin; Teodora Chamova; Matthis Synofzik; Dagmar Timmann; Tine Holemans; Albena Andreeva; Jennifer Reichbauer; Riet De Rycke; Dae-In Chang; Sarah van Veen; Jean Samuel; Ludger Schöls; Thorsten Pöppel; Danny Mollerup Sørensen; Bob Asselbergh; Christine Klein; Stephan Zuchner; Albena Jordanova; Peter Vangheluwe; Ivailo Tournev; Rebecca Schüle
Journal:  Brain       Date:  2017-02       Impact factor: 13.501

8.  SPG11 spastic paraplegia. A new cause of juvenile parkinsonism.

Authors:  Mathieu Anheim; Clotilde Lagier-Tourenne; Giovanni Stevanin; Marie Fleury; Alexandra Durr; Izzie Jacques Namer; Paola Denora; Alexis Brice; Jean-Louis Mandel; Michel Koenig; Christine Tranchant
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

9.  Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.

Authors:  Coro Paisán-Ruiz; Rocio Guevara; Monica Federoff; Hasmet Hanagasi; Fardaz Sina; Elahe Elahi; Susanne A Schneider; Petra Schwingenschuh; Nin Bajaj; Murat Emre; Andrew B Singleton; John Hardy; Kailash P Bhatia; Sebastian Brandner; Andrew J Lees; Henry Houlden
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

Review 10.  The pallidopyramidal syndromes: nosology, aetiology and pathogenesis.

Authors:  Eleanna Kara; John Hardy; Henry Houlden
Journal:  Curr Opin Neurol       Date:  2013-08       Impact factor: 5.710
View more
  1 in total

Review 1.  Pallidal degenerations and related disorders: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-08-07       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.